Recombinant adenovirus carrying glial cell line2derived neurotrophic factor gene protect midbra in dopaminergic neurons in mice
|
|
- Laureen Melton
- 5 years ago
- Views:
Transcription
1 256 ( ) JOURNAL OF PEKIN G UNIVERSITY( HEAL TH SCIENCES) Vol. 35 No. 3 J une 2003 ( ) [ ] ; ;MPTP [ ] : (r GDNF) (DA) 2 2 (MPTP) :LacZ (Ad2LacZ) 24 h 72 h 10 d 30 d X2Gal ;r GDNF (Ad2r GDNF) 72 h MPTP DA 1 DA 3 42 (DOPAC) ( HVA) :Ad2LacZ 24 h 72 h 10 d 30 d LacZ Ad2r GDNF DA MPTP MPTP + Ad2LacZ DA DOPAC HVA DOPAC/ DA HVA/ DA :Ad2r GDNF DA MPTP [ ] R74215 [ ] A [ ] X(2003) Recombinant adenovirus carrying glial cell line2derived neurotrophic factor gene protect midbra in dopaminergic neurons in mice GAO Hong WAN G Jianjun ZHAN G Wei J IAN G Yuhui N IU Dongbin WAN G Xiaomin (Neuroscience Research Institute Peking University ; Department of Neurobiology Peking University School of Basic Medical Sciences Beijing China) KEY WORDS Parkinson disease ; Glial cell line2derived neurotrophic factor ; Recombinant adenovirus ; Dopamine ; MPTP SUMMARY Objective : To observe the protective effects of recombinant adenovirus expressing glial cell line2derived neurot rop hic factor ( Ad2r GDN F) on t he midbrain dopaminergic neurons against M P TP damage. Methods : Recombinant adenovirus carrying LacZ gene ( Ad2LacZ) was injected into t he murine st riat um using t he stereotaxic apparat us. The murine brains were perf used and dissected t hen stained with X2Gal subsequently at 24 hours 72 hours 10 days and 30 days after injection. In another experiment MPTP was injected subcutaneously into the mice 72 hours after the intrastriatal injection of Ad2r GDNF ( pfu ml - 1 ). The murine striatum was removed to evaluate the content of DA DOPAC and HVA by HPLC2ECD 1 week later. Results : X2Gal staining indicated the expression of LacZ gene 24 hours after injection of Ad2LacZ. Stronger expression was also detected at the end of 72 hours and 10 days but decreased 30 days later. In addition the LacZ gene expression was localized and detectable in bot h neurons and glial cells. There was no apparent cytotoxic effect induced by Ad2 LacZ alone. In MPTP2treated mice the content of dopamine decreased 80 % compared to that in the saline2treated ones. The DA content of MPTP + Ad2r GDNF group on injected side was significantly higher t han t hat of M P TP alone group and M P TP + Ad2LacZ group. Changes in t he content of DOPAC and HVA followed t he same pattern. The ratio of DOPAC/ DA and HVA/ DA on injected side also decreased significantly. However no significant change was observed on uninjected side. Conclu2 sion : The result s suggested t hat recombinant adenoviral vector expressing r GDN F can protect DA neu2 rons against MPTP injury. ( J Peking U niv [ Health Sci ] : ) : ( G ) ( ) Supported by the Major State Basic Research Development Program of People s Republic of China ( G ) and the National Natural Science Foundation of China ( ) Corresponding author edu. cn
2 257 ( Parkinson s disease PD) PBS ml (dopamine DA) l h 48 h PD 45 d 68 DA d : (pfu DA ml - 1 ) = pfu (plaque forming unit pfu) ( glial cell line2derived neurot rop hic fac2 tor GDNF) TGF2 pfu ml pfu ml - 1 DA 1. 3 [1 DA ] C57BL/ 6J ( DA 62 (62hydroxydopa2 ) g 4 : mine 62OHDA) 2 2 (12met hyl242 phenyl2l tetrohydropyridine MPTP) Ad2LacZ MPTP ; ( 4) Ad2r GDNF [2 ] PD MPTP Ad2r GDNF GDNF Ad2LacZ MPTP PBS 72 h MPTP 40 mg kg HPLC2ECD [3 4 ] GDNF DA 3 42 (3 GDNF dihydroxyphenylacetic acid DOPAC) DA (homovanillic acid HVA) GDNF PD 1. 4 X2Gal GDNF PBS/ % ( MPTP PD ) min Ad2 PBS/ 3 (1 3 2 r GDNF DA MPTP 10 min) 37 X2Gal 24 h %( ) DMEM % PBS 0. 5 ml A (0. 4 mmol L - 1 HClO 4 23 ml [5 2 ml ] l2 h 5 % ( ) l min 10 min r min - 1 DMEM 15 min 1/ 2 2 ml B (6. 4 g g DMEM g ED TA ml ) l ml DMEM l ECD 0. 8 V 40 min ml 0. 9 ml DMEM 0. 1 ml GDNF LacZ (1) ; (2) MPTP ; (3) 70 % 80 % 90 % 5 min ml) 10 min r min min MPa 12 ml min l
3 258 ( ) JOURNAL OF PEKIN G UNIVERSITY( HEAL TH SCIENCES) Vol. 35 No. 3 J une Ad2r GDNF DA MPTP 1. 7 STA TISTICA One Way ANOVA Newman2Keuls post hoc gx s gx 2030 min 24 h Ad2LacZ pfu ml - 1 Ad2LacZ 4 l 24 h X2Gal Ad2r GDNF LacZ (1A B) 72 h MPTP DA (1 C D) 10 d DOPAC HVA DA MPTP 40 mg kg - 1 (1E F) 30 d LacZ DA DOPAC HVA (1 G F) (1) DA DOPAC/ DA HVA/ DA HVA/ DA 4 (2) C57BL/ 6J MPTP 40 mg kg min 1 Ad r GDNF MPTP DA DOPAC HVA Table 1 The effect of recombinant adenovirus Ad r GDNF on the content of DA DOPAC and HVA Group n Uninjection side DA DOPAC HVA Injection side DA DOPAC HVA Control MPTP MPTP + Ad2LacZ MPTP + Ad2r GDNF amount of substance per g tissue ; 3 P < P < vs the injection side of MPTP + Ad2r GDNF group1 2 Ad r GDNF MPTP DOPAC/ DA HVA/ DA Table 2 The effect of recombinant adenovirus Ad r GDNF on the ratio of DOPAC/ DA and HVA/ DA Group n Uninjection side DOPAC/ DA HVA/ DA Injection side DOPAC/ DA HVA/ DA Control MPTP MPTP + Ad2LacZ # # MPTP + Ad2r GDNF P < P < vs the injection side of MPTP + Ad2r GDNF group ; # P < vs the uninjection side of MPTP + Ad2LacZ group1
4 259 A( 50) B ( 200) : 24 hours after injection ; C( 50) D ( 200) : 72 hours after injection ; E( 50) F( 200) : 10 days after injection ; G( 50) H( 200) : 30 days after injection. 1 LacZ Figure 1 Expression of LacZ in murine striatum Ad2r GDNF 3 DA DOPAC HVA DA C57BL/ 6J MPTP 72 h pfuml - 1 Ad2r GDNF 62OHDA MPTP MPTP 4 l Ad2r GDNF DA PD MPTP [6 ] C57BL/ 6J Ad2LacZ 1 Ad2r GDNF Heikkila [7 ] C57BL/ 6J DA MPTP 40 mg kg - 1 MPTP 12 d Ad2LacZ (81 18) % DA 80 % DOPAC HVA ( 23 5 ) % DA PD DA DOPAC HVA Ad2r GDNF C57BL/ 6J MPTP Ad2LacZ 100 % 2 Ad2r GDNF DOPAC/ DA HVA/ DA MPTP Ad2 (2025 g) LacZ Ad2r GDNF DA 78 % DA DOPAC HVA MPTP DA Ad2LacZ 89 % MPTP DOPAC/ DA HVA/ DA MPTP C57BL/ 6J DA DA Ad2r GDNF Ad2 PD PD (2530 g) DA MPTP LacZ DA
5 260 ( ) JOURNAL OF PEKIN G UNIVERSITY( HEAL TH SCIENCES) Vol. 35 No. 3 J une 2003 Irwin [8 ] r GDNF DA MPTP DA PD [16 ] LacZ Ad2LacZ LacZ [9211 ] Ridoux [12 ] PD GDNF GDNF 62OHDA DA [13 ] [14 MPTP DA ] [5 ] r GDNF LacZ Ad2r GDNF SH2SY5 Y [J ]. PC12 MN9D DA MN9D MPTP [15 ] Ad2r GDNF DA MPTP LacZ Ad2LacZ Ad2LacZ pfu ml - 1 Ad2r GDNF 72 h MPTP DA Ad2r GDNF DA DOPAC HVA MPTP Ad2 LacZ DA DOPAC/ DA HVA/ DA [ 14 ] DA DA DOPAC HVA DA ; DOPAC/ DA HVA/ DA DOPAC HVA DOPAC/ DA HVA/ DA Ad2 1 Lin L F Doherty DH Lile JD et al. GDNF : a glial cell line2de2 rived neurotrophic factor for midbrain dopaminergic neurons [ J ]. Science (5111) : Tomac A Lindqvist E Lin L F et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo [ J ]. Nature (6512) : Hudson J Granholm AC Gerhardt GA et al. Glial cell line2de2 rived neurotrophic factor augments midbrain dopaminergic circuits i n vivo[j ]. Brain Res Bull (5) : Gash DM Zhang Z Ovadia A et al. Functional recovery in parkinsonian monkeys treated with GDNF[J ]. Nature (6571) : GDNF : Gerlach M Riederer P Przuntek H et al. MPTP mechanisms of neurotoxicity and their implications for Parkinson s disease[j ]. Eur J Pharmacol (4) : Heikkila RE Sieber BA Manzino L et al. Some features of the nigrostriatal dopaminergic neurotoxin 12methyl242phenyl tetrahydropyridine ( MPTP) in the mouse [ J ]. Mol Chem Neu2 ropathol (3) : Irwin I DeLanney L E Forno LS et al. The evolution of nigros2 triatal neurochemical changes in the MPTP2 treated squirrel monkey [J ]. Brain Res (122) : Akli S Caillaud C Vigne E et al. Transfer of a foreign gene into the brain using adenovirus vectors [J ]. Nat Genet ( 3) : Bajocchi G Feldman SH Crystal RG et al. Direct i n vivo gene transfer to ependymal cells in the central nervous system using re2 combinant adenovirus vectors[j ]. Nat Genet ( 3) : Le Gal LS Robert JJ Berrard S et al. An adenovirus vector for gene transfer into neurons and glia in the brain[j ]. Science (5097) : Ridoux V Robert JJ Zhang X et al. Adenoviral vectors as func2 tional retrograde neuronal tracers[j ]. Brain Res (1) : 13 Choi2Lundberg DL Lin Q Chang YN et al. Dopaminergic neu2 rons protected from degeneration by GDNF gene therapy[j ]. Sci2 ence (5301) : Kojima H Abiru Y Sakajiri K et al. Adenovirus2mediated trans2 duction with human glial cell line2derived neurotrophic factor gene prevents 12methyl242phenyl tetrahydropyridine2induced dopamine depletion in striatum of mouse brain[j ]. Biochem Biophys Res Commun (2) : GDNF MN9D [ J ] : Peltekian E Parrish E Bouchard C et al. Adenovirus2mediated gene transfer to the brain : methodological assessment [J ]. J Neu2 rosci Methods (1) : ( ) ( : )
MATERIALS AND METHODS
Proc. Natl. Acad. Sci. USA Vol. 94, pp. 8818 8823, August 1997 Neurobiology Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic
More informationPERSPECTIVE. Localized striatal delivery of GDNF as a treatment for Parkinson disease. Deniz Kirik, Biljana Georgievska & Anders Björklund
Localized striatal delivery of GDNF as a treatment for Parkinson disease Deniz Kirik, Biljana Georgievska & Anders Björklund Ten years ago, a glial cell line derived neurotrophic factor (GDNF) that has
More informationStem Cells and The Endometrium. Director, Division of Reproductive Endocrinology and infertility
Stem Cells and The Endometrium Hugh S. Taylor, M.D. Director, Division of Reproductive Endocrinology and infertility Nothing to disclose Stem Cells Cells that are capable of both self-renewal and have
More informationSullivan, Aideen M.; Toulouse, André. Article (peer-reviewed)
Title Author(s) Neurotrophic factors for the treatment of Parkinson's disease Sullivan, Aideen M.; Toulouse, André Publication date 2011-06 Original citation Type of publication Link to publisher's version
More informationTowards a neuroprotective gene therapy for Parkinson s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF 1
Brain Research 886 (2000) 82 98 www.elsevier.com/ locate/ bres Interactive report Towards a neuroprotective gene therapy for Parkinson s disease: use of adenovirus, AAV and lentivirus vectors for gene
More informationProtective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons 1
Chen XC et al / Acta Pharmacol Sin 2002 Sep; 23 (9): 829-834 829 2002, Acta Pharmacologica Sinica ISSN 1671-4083 Shanghai Institute of Materia Medica Chinese Academy of Sciences http://www.chinaphar.com
More informationTitle: Restorative Effects of Uridine Plus Docosahexaenoic Acid in a Rat Model of Parkinson's Disease
Elsevier Editorial System(tm) for Neuroscience Research Manuscript Draft Manuscript Number: NSR-D-08-00172R1 Title: Restorative Effects of Uridine Plus Docosahexaenoic Acid in a Rat Model of Parkinson's
More information,, : Current Status in Drug Addiction and Addiction Memory Research WAN G Hao2Ran 1, GAO Xiang2 Rong 1, ZHAN G Kai2Gao 2, HAN Ji2Sheng 1 ( 1
202 2003 34 3 1 1 2 1 1 2 ( 100083) : R749. 91 Current Status in Drug Addiction and Addiction Memory Research WAN G Hao2Ran 1 GAO Xiang2 Rong 1 ZHAN G Kai2Gao 2 HAN Ji2Sheng 1 ( 1 D rug Dependence Peki
More informationGene Therapy (2003) 10, & 2003 Nature Publishing Group All rights reserved /03 $
(2003) 10, 1721 1727 & 2003 Nature Publishing Group All rights reserved 0969-7128/03 $25.00 www.nature.com/gt REVIEW Gene therapy progress and prospects: Parkinson s disease EA Burton 1, JC Glorioso 2
More informationCERE-120 (AAV-Neurturin) for Parkinson s Disease
CERE-120 (AAV-Neurturin) for Parkinson s Disease NIH OBA Protocol # 0501-689 A Phase I, Open-Label Study of CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN] to Assess the Safety and Tolerability
More informationGlial cell line-derived neurotrophic factor (GDNF) gene therapy in an aged rat model of Parkinson's disease
Gene Therapy and Molecular Biology Vol 4, page 59 Gene Ther Mol Biol Vol 4, 59-74. December 1999. Glial cell line-derived neurotrophic factor (GDNF) gene therapy in an aged rat model of Parkinson's disease
More informationExperimental and Clinical Neurotoxicology
Experimental and Clinical Neurotoxicology SECOND EDITION ---o * -6- Edited by PETER S. SPENCER, Ph.D., F.R.C.Path. Senior Scientist and Director Center for Research on Occupational and Environmental Toxicology
More informationAdenovirus-mediated delivery of GDNF ameliorates corticospinal neuronal atrophy and motor function de cits in rats with spinal cord injury
MOTOR SYSTEMS Adenovirus-mediated delivery of GDNF ameliorates corticospinal neuronal atrophy and motor function de cits in rats with spinal cord injury Xiao-Qing Tang, Yun Wang, Zhi-Hua Huang, Ji-Sheng
More informationThe Pennsylvania State University The Graduate School College of Health and Human Development HOST SUSCEPTIBILITY TO ENVIRONMENTAL TOXICANTS
The Pennsylvania State University The Graduate School College of Health and Human Development HOST SUSCEPTIBILITY TO ENVIRONMENTAL TOXICANTS A Dissertation in Biobehavioral Health by Gelareh Alam 2015
More informationGBME graduate course. Chapter 43. The Basal Ganglia
GBME graduate course Chapter 43. The Basal Ganglia Basal ganglia in history Parkinson s disease Huntington s disease Parkinson s disease 1817 Parkinson's disease (PD) is a degenerative disorder of the
More informationParkinson s disease (PD) results from the dysfunction and degeneration
Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson s disease Navin Maswood*, Jennifer Young, Edward Tilmont, Zhiming
More informationGreen Tea Polyphenol Epigallocatechin-3-Gallate Attenuates Behavioral Abnormality in Hemi-Parkinsonian Rat
Iranian Biomedical Journal 1 (4): 23-27 (October 26) Green Tea Polyphenol Epigallocatechin-3-Gallate Attenuates Behavioral Abnormality in Hemi-Parkinsonian Rat Tourandokht Baluchnejadmojarad *1 and Mehrdad
More informationADAM O. HEBB, M.D., KARI HEBB, B.SC., ARUN C. RAMACHANDRAN, ADM.SCI., AND IVAR MENDEZ, M.D., PH.D.
J Neurosurg 98:1078 1083, 2003 Glial cell line derived neurotrophic factor supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage ADAM
More informationNEUROPLASTICITY IN THE NIGROSTRIATAL SYSTEM OF MPTP-TREATED MICE AT THE PRESYMPTOMATIC AND EARLY SYMPTOMATIC STAGES OF PARKINSONISM
NEUROPLASTICITY IN E NIGROSTRIATAL SYSTEM OF MPTP-TREATED MICE AT E PRESYMPTOMATIC AND EARLY SYMPTOMATIC STAGES OF PARKINSONISM Michael V. Ugrumov Institute of Developmental Biology RAS, Moscow, Russia
More informationNeurosurg Focus 7 (3):Article 4, 1999
Neurosurg Focus 7 (3):Article 4, 1999 Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line derived neurotrophic
More informationRole of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
Proc. Natl. Acad. Sci. USA Vol. 93, pp. 4565-4571, May 1996 Neurobiology Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity (nitric
More informationThe role of pramipexole in a severe Parkinson s disease model in mice
Therapeutic Advances in Neurological Disorders Original Research The role of pramipexole in a severe Parkinson s disease model in mice Seham Gad ElHak, Abdel Aziz Ghanem, Hasan Abdelghaffar, Sahar ElDakroury,
More informationNeuroprotection in preclinical models of Parkinson disease by the NAPVSIPQ peptide
Neuroprotection in preclinical models of Parkinson disease by the NAPVSIPQ peptide Bruce H. Morimoto, Ph.D. Executive Director, Applied Translational Medicine Microtubules Microtubules essential for neuronal
More informationTITLE: Pharmacological and Behavioral Enhancement of Neuroplasticity in the MPTP- Lesioned Mouse and Nonhuman Primate
AD Award Number: W81XWH-04-1-0444 TITLE: Pharmacological and Behavioral Enhancement of Neuroplasticity in the MPTP- Lesioned Mouse and Nonhuman Primate PRINCIPAL INVESTIGATOR: Giselle Petzinger, M.D. Michael
More informationChanges in long2term syna ptic plasticity in the spinal dorsal horn of neuropathic pa in rats
226 ( ) JOURNAL OF PEKIN G UNIVERSITY( HEAL TH SCIENCES) Vol. 35 No. 3 J une 2003,,, (, 100083) [ ] / ; ; ; / [ ] :, (central sensitization) :Sprague2Dawley 5/ 6 (L5/ L6), C2, C2 L TP : (1), ( 100 Hz,
More informationAtsushi Fujita 1, Hiroo Yamaguchi 1, Ryo Yamasaki 1, Yiwen Cui 1, Yuta Matsuoka 2, Ken-ichi Yamada 2 and Jun-ichi Kira 1*
Fujita et al. Journal of Neuroinflammation (2018) 15:227 https://doi.org/10.1186/s12974-018-1251-0 RESEARCH Open Access Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration
More informationClinical Study Intensive Rehabilitation Treatment in Parkinsonian Patients with Dyskinesias: A Preliminary Study with 6-Month Followup
Parkinson s Disease Volume 2012, Article ID 910454, 4 pages doi:10.1155/2012/910454 Clinical Study Intensive Rehabilitation Treatment in Parkinsonian Patients with Dyskinesias: A Preliminary Study with
More informationTITLE: Pharmacological and Behavioral Enhancement of Neuroplasticity in the MPTP- Lesioned Mouse and Nonhuman Primate
AD Award Number: W81XWH-04-1-0444 TITLE: Pharmacological and Behavioral Enhancement of Neuroplasticity in the MPTP- Lesioned Mouse and Nonhuman Primate PRINCIPAL INVESTIGATOR: Giselle Petzinger, M.D. Michael
More informationTITLE: Neurotrophic Response to CNS Degeneration or Injury: Effects of Aging
AD Award Number: DAMD17-01-1-0766 TITLE: Neurotrophic Response to CNS Degeneration or Injury: Effects of Aging PRINCIPAL INVESTIGATOR: David M. Yurek, Ph.D. Kim B. Seroogy, Ph.D. CONTRACTING ORGANIZATION:
More informationNeuronal and Astroglial Responses to the Serotonin and Norepinephrine Neurotoxin: 1-Methyl-4-(2 -aminophenyl)- 1,2,3,6-tetrahydropyridine
0022-3565/03/3073-923 931$7.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 307, No. 3 Copyright 2003 by The American Society for Pharmacology and Experimental Therapeutics 55749/1112658
More informationAnalysis of volatile organic compounds in rats with dopaminergic lesion: possible application for early detection of Parkinson s disease
Oxidative Stress laboratory Analysis of volatile organic compounds in rats with dopaminergic lesion: possible application for early detection of Parkinson s disease By Dr. Soliman Khatib Senior lecturer,
More informationReceived August 3, 2012; revised September 7, 2012; accepted September 21, 2012
Journal of Behavioral and Brain Science, 2012, 2, 485-494 http://dx.doi.org/10.4236/jbbs.2012.24057 Published Online November 2012 (http://www.scirp.org/journal/jbbs) Prenatal and Postnatal Exposures to
More informationANIMAL MODELS OF PARKINSON S DISEASE: STATE OF THE FIELD & THE FUTURE! KULDIP DAVE
ANIMAL MODELS OF PARKINSON S DISEASE: STATE OF THE FIELD & THE FUTURE! KULDIP DAVE 21 February 217 MJFF IS THE WORLD S LARGEST NONPROFIT FUNDER OF PD RESEARCH Our Mission To accelerate the development
More informationNeurotrophic and Neuroprotective Effects of Tripchlorolide, an Extract of Chinese Herb Tripterygium wilfordii Hook F, on Dopaminergic Neurons
Experimental Neurology 179, 28 37 (2003) doi:10.1006/exnr.2002.8049 Neurotrophic and Neuroprotective Effects of Tripchlorolide, an Extract of Chinese Herb Tripterygium wilfordii Hook F, on Dopaminergic
More informationMaking Every Little Bit Count: Parkinson s Disease. SHP Neurobiology of Development and Disease
Making Every Little Bit Count: Parkinson s Disease SHP Neurobiology of Development and Disease Parkinson s Disease Initially described symptomatically by Dr. James Parkinson in 1817 in An Essay on the
More informationREVIEW ENDOGENOUS RISK FACTORS IN PARKINSON S DISEASE: DOPAMINE AND TETRAHYDROISOQUINOLINES 1. Lucyna Antkiewicz-Michaluk
Copyright 2002 by Institute of Pharmacology Polish Academy of Sciences Polish Journal of Pharmacology Pol. J. Pharmacol., 2002, 54, 567 572 ISSN 1230-6002 REVIEW ENDOGENOUS RISK FACTORS IN PARKINSON S
More informationModeling Parkinson s disease: systems to test gene-environment interactions
Modeling Parkinson s disease: systems to test gene-environment interactions Jason Cannon, Ph.D. Pittsburgh Institute of Neurodegenerative Diseases University of Pittsburgh Outline Parkinson s disease (PD)
More informationCONTRACTING ORGANIZATION: University of Wisconsin-Madison Madison, WI 53705
AD Award Number: DAMD17-03-1-0122 TITLE: Regulated GDNF Delivery in Vivo Using Neural Stem Cells PRINCIPAL INVESTIGATOR: Clive Svendsen CONTRACTING ORGANIZATION: University of Wisconsin-Madison Madison,
More informationEffects of limbic corticostriatal lesions on a u t o shaping performance in rats
Effects of limbic corticostriatal lesions on a u t o shaping performance in rats BJ Everitt, JA Parkinson, G Lachenal, KM Halkerston, N Rudarakanchana, RN Cardinal, J Hall, CH Morrison, JW Dalley, SR Howes,
More informationClues to the mechanism underlying dopamine cell
Journal ofneurology, Neurosurgery, and Psychiatry. Special Supplement 1989:22-28 Clues to the mechanism underlying dopamine cell death in Parkinson's disease P JENNER From the Parkinson's Disease Society
More informationStrategies for Neurorestoration: Growth Factors
Strategies for Neurorestoration: Growth Factors Elena Posse de Chaves, PhD 928-MSB Phone: 492-5966 Email: elena.chaves@ualberta.ca Treatment of Neurodegenerative Diseases Most neurodegenerative diseases
More informationARTICLE IN PRESS Behavioural Brain Research xxx (2011) xxx xxx
Behavioural Brain Research xxx (2011) xxx xxx Contents lists available at SciVerse ScienceDirect Behavioural Brain Research j ourna l ho mepage: www.elsevier.com/locate/bbr Research report Ethyl-eicosapentaenoate
More informationEmbargoed until Oct. 18, 10:30 a.m. CDT Contacts: Kat Snodgrass, (202) Press Room, Oct : (312) Sarah Bates, (202)
Embargoed until Oct. 18, 10:30 a.m. CDT Contacts: Kat Snodgrass, (202) 962-4090 Press Room, Oct. 17 21: (312) 791-6619 Sarah Bates, (202) 962-4087 RUN FOR YOUR LIFE: NEW STUDIES SHOW BENEFITS OF EXERCISE
More information1ME A17R11 WI238 DMS2114 JC L2929 P815 PT67
20 1 2004 1 Chinese Journal of Biotechnology Vol. 20 No. 1 January 2004 3 (, 361005), BacV2CMV2EGFPA,Sf9, 20, 12,7,1 CMV,,,LipofectAMINE CMV EGFP pcdna3112egfp, CMV EGFP, CMV CMV,,,,,, Bac2to2Bac 2, CMV,,,
More informationAlterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-b-carboline
J Neural Transm (2009) 116:1267 1271 DOI 10.1007/s00702-009-0261-6 MOVEMENT DISORDERS - ORIGINAL ARTICLE Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin
More informationUniversitätsklinikum Ulm Institut für Pharmakologie und Toxikologie Leiter: Prof. Dr. Peter Gierschik
Universitätsklinikum Ulm Institut für Pharmakologie und Toxikologie Leiter: Prof. Dr. Peter Gierschik Establishment of mass spectrometric determination of the biomarkers camp and cgmp and investigation
More informationWistar DA DOPAC DOPAC G804.7 A (2013)
31 1. 410072 2. 410128 Wistar (CM)(CS)(EM) (ES)( 10 ) CM EM EM ES 4 - (DA)5-(5-HT)(NE)(DOPAC)5- (5-HIAA)3-4-(MHPG)CS ES 24 h TTC CS ES (P
More informationNeuroprotection through Delivery of Glial Cell Line-Derived Neurotrophic Factor by Neural Stem Cells in a Mouse Model of Parkinson s Disease
The Journal of Neuroscience, October 15, 2001, 21(20):8108 8118 Neuroprotection through Delivery of Glial Cell Line-Derived Neurotrophic Factor by Neural Stem Cells in a Mouse Model of Parkinson s Disease
More informationRecovery of Presynaptic Dopaminergic Functioning in Rats Treated with Neurotoxic Doses of Methamphetamine
The Journal of Neuroscience, September 1, 1999, 19(17):7653 7660 Recovery of Presynaptic Dopaminergic Functioning in Rats Treated with Neurotoxic Doses of Methamphetamine Wayne A. Cass and Michael W. Manning
More informationCURRICULUM VITAE. Jonathan Dickerson B.S. Biology, Wilmington College.
CURRICULUM VITAE Jonathan Dickerson Education: 1999-2003 B.S. Biology, Wilmington College. 2004-2010 Ph.D., Neuroscience Graduate Program, University of Cincinnati. Thesis Advisor: Dr. Kim Seroogy 2007
More informationCombined Nurr1 and Foxa2 roles in the therapy of Parkinson s disease
Research Article Combined Nurr1 and Foxa2 roles in the therapy of Parkinson s disease Sang-Min Oh 1,2,3, Mi-Yoon Chang 2, Jae-Jin Song 1,2,3, Yong-Hee Rhee 1,2,3, Eun-Hye Joe 4, Hyun-Seob Lee 5, Sang-Hoon
More informationImpact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson s Disease
Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson s Disease FABIO G. TEIXEIRA,MIGUEL M.CARVALHO KRISHNA M. PANCHALINGAM ANA J.RODRIGUES
More informationJournal of ChineseMedicinalMaterials H 2 O 2. Effects of EGb 761 on the Cell Apoptosis Induced by H 2 O 2 in R IN 2m Beta Cells
424 H 2 O 2 R IN2m,,, (, 510632) : ( Ginkgo biloba extract, EGb761) (Hydrogen peroxide, H 2 O 2 ) RIN2m : 500 mol/l H 2 O 2 RIN2m 6h ; (Control) (H 2 O 2 ) ( Que 100 mol/l) EGb 761 ( EGb 761 100 mol/l),
More informationThis is a free sample of content from Parkinson's Disease. Click here for more information or to buy the book.
A AADC. See Aromatic amino acid decarboxylase AAV. See Adeno-associated virus Acetylcholine (ACh), functional imaging, 174 175 ACh. See Acetylcholine Adaptive immune system central nervous system, 381
More informationIntroduction. Cheongju, Chungbuk 28644, Korea
Natural Product Sciences 22(3) : 187-192 (2016) http://dx.doi.org/10.20307/nps.2016.22.3.187 Effects of Gypenosides on Dopaminergic Neuronal Cell Death in 6-Hydroxydopamine-lesioned Rat Model of Parkinson
More informationNeurturin Exerts Potent Actions on Survival and Function of Midbrain Dopaminergic Neurons
The Journal of Neuroscience, July 1, 1998, 18(13):4929 4937 Neurturin Exerts Potent Actions on Survival and Function of Midbrain Dopaminergic Neurons Brian A. Horger, 1 Merry C. Nishimura, 1 Mark P. Armanini,
More informationNSCs), broblast growth factor, bfgf) ( Peprotech ) ; NSCs
Chinese Journal of Pathophysiology 2003,19 (3) :289-292 289 [ ] 1000-4718 (2003) 03-0289 - 04 3 1, 1, 2, 1, 1, 1, 1, 2 ( 1, 2, 510060) [ ] :( ESCs) (NSCs) : ESCs, m ller,nscs 7 d,, RT - PCR nestin glutaminase
More informationChanges in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys
Journal of Neurochemistry, 2002, 80, 168±177 Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys Greg A. Gerhardt, Wayne A. Cass, Ai Yi, Zhiming Zhang and Don M. Gash
More informationElectro-acupuncture improves behavior and upregulates GDNF mrna in MFB transected rats
MOTOR SYSTEMS Electro-acupuncture improves behavior and upregulates GDNF mrna in MFB transected rats Xi-Bin Liang, 1 Yong Luo, Xian-Yu Liu, Jun Lu, Feng-Qiao Li, 2 Qian Wang, Xiao-Min Wang CA and Ji-Sheng
More informationMinocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson s disease
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson s disease Yansheng Du*, Zhizhong Ma*, Suizhen Lin*, Richard C. Dodel, Feng Gao*, Kelly R. Bales, Lazarose
More informationSpinal motor neurons from neonatal rats: purification, culture and identification doi: /j.issn
19 42 2015 10 08 Chinese Journal of Tissue Engineering Research October 8, 2015 Vol.19, No.42 (/ 116024), (2013023035)(2013E15SF171) Hoechst 85.8% 71.6% 7.8% NF200 6.4% 1987 116024 :R318 :B :2095-4344
More informationEXPERIMENTAL AND THERAPEUTIC MEDICINE 11: , 2016
EXPERIMENTAL AND THERAPEUTIC MEDICINE 11: 101-109, 2016 Evaluation of the early response and mechanism of treatment of Parkinson's disease with L-dopa using 18 F-fallypride micro-positron emission tomography
More informationNovel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson s disease
Baranyi et al. Molecular Neurodegeneration (2016) 11:6 DOI 10.1186/s13024-015-0067-y RESEARCH ARTICLE Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson
More informationAbsence of Ret Signaling in Mice Causes Progressive and Late Degeneration of the Nigrostriatal System
Absence of Ret Signaling in Mice Causes Progressive and Late Degeneration of the Nigrostriatal System PLoS BIOLOGY Edgar R. Kramer 1*, Liviu Aron 1, Geert M. J. Ramakers 2, Sabine Seitz 3,4, Xiaoxi Zhuang
More informationRegulation of Astroglial-Derived Dopaminergic Neurotrophic Factors by Interleukin-1 in the Striatum of Young and Middle-Aged Mice 1
EXPERIMENTAL NEUROLOGY 148, 348 359 (1997) ARTICLE NO. EN976659 Regulation of Astroglial-Derived Dopaminergic Neurotrophic Factors by Interleukin-1 in the Striatum of Young and Middle-Aged Mice 1 Angela
More informationLUP. Lund University Publications Institutional Repository of Lund University
LUP Lund University Publications Institutional Repository of Lund University This is an author produced version of a paper published in Biochimica et biophysica acta. This paper has been peerreviewed but
More informationNeurotrophic Effects of Growth/Differentiation Factor 5 in a Neuronal Cell Line
Neurotox Res (2012) 21:256 265 DOI 10.1007/s12640-011-9266-7 Neurotrophic Effects of Growth/Differentiation Factor 5 in a Neuronal Cell Line André Toulouse Grace C. Collins Aideen M. Sullivan Received:
More informationEffects of 6-hydroxydopamine on the Adult Neurogenesis of Dopaminergic Neurons in the Mouse Midbrain
Experimental Neurobiology Vol. 18, pages 26 31, June 2009 Effects of 6-hydroxydopamine on the Adult Neurogenesis of Dopaminergic Neurons in the Mouse Midbrain Tae Woo Kim, Hyun Kim and Woong Sun* Department
More informationBrain dopamine and mild hypoxia
Brain dopamine and mild hypoxia Denoroy L, Orset C, Parrot S, Berod A, Sauvinet V, Cottet-Emard JM, Pequignot JM. Université Claude Bernard, Lyon, France Striatum vulnerable to hypoxia ischemia necrotic
More informationTHE EXPRESSION OF INOS IN MOUSE EXPERIMENTAL MODEL POINTS TO INFLAMMATORY CONDITIONS ASSOCIATED WITH PARKINSON S DISEASE
THE EXPRESSION OF INOS IN MOUSE EXPERIMENTAL MODEL POINTS TO INFLAMMATORY CONDITIONS ASSOCIATED WITH PARKINSON S DISEASE Fatima Laiche Noureddine Djebli Mostaganem University, Algeria Abstract Parkinson
More informationSuberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage
494..505 British Journal of Pharmacology DOI:10.1111/j.1476-5381.2011.01575.x www.brjpharmacol.org RESEARCH PAPERbph_1575 Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic
More informationNIH Public Access Author Manuscript Parkinsonism Relat Disord. Author manuscript; available in PMC 2009 January 1.
NIH Public Access Author Manuscript Published in final edited form as: Parkinsonism Relat Disord. 2008 ; 14(Suppl 2): S84 S87. doi:10.1016/j.parkreldis.2008.04.004. Strengths and Limitations of Genetic
More informationPROPOSAL: Translational Safety Biomarker Assessment of Neurotoxicity
PROPOSAL: Translational Safety Biomarker Assessment of Neurotoxicity Andreas Jeromin, PhD Chief Scientific Officer NextGen Sciences DX Boston, MA Emerging Issues Session HESI Annual Meeting 12 June 2012
More informationand mitigates features of Parkinson disease
D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease Kim Tieu, 1 Celine Perier, 1 Casper Caspersen, 2 Peter Teismann, 1 Du-Chu Wu, 1 Shi-Du Yan, 2,3 Ali Naini,
More information*,1 R.E. Ryan, 2 S.A. Ross, 2 J. Drago & 1 R.E. Loiacono. Introduction
British Journal of Pharmacology (2001) 132, 1650 ± 1656 ã 2001 Nature Publishing Group All rights reserved 0007 ± 1188/01 $15.00 Dose-related neuroprotective e ects of chronic nicotine in 6-hydroxydopamine
More information1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium
FEBS Letters 461 (1999) 196^200 FEBS 22878 1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium Honglian Shi, Noriko Noguchi,
More informationThe Opportunity: Parkinson s disease, RLS, ADHD, and disease modification YKP10461
The Opportunity: Parkinson s disease, RLS, ADHD, and disease modification YKP10461 1 TABLE OF CONTENTS Profile Summary Mechanism of Action Clinical Study Results Pharmacologic Profile Safety and Toxicity
More informationNeuroprotective Effect of Kaempferol against a 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Mouse Model of Parkinson s Disease
August 2011 Regular Article Biol. Pharm. Bull. 34(8) 1291 1296 (2011) 1291 Neuroprotective Effect of Kaempferol against a 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Mouse Model of Parkinson
More informationAvailable online at
Journal of Basic and Clinical PATHOPHYSIOLOGY Available online at http://jbcp.shahed.ac.ir/ Volume 4, Number 1, Autumn-Winter 2015-2016 Malva sylvestris aqueous extract could ameliorate 6-hydroxydopamine-induced
More informationSanneke van Vliet, Raymond Vanwersch, Marjan Jongsma, Jan van der Gugten, Berend Olivier, Ingrid Philippens
Neuroprotective effects of Δ 9 -tetrahydrocannabinol in a marmoset Parkinson model Sanneke van Vliet, Raymond Vanwersch, Marjan Jongsma, Jan van der Gugten, Berend Olivier, Ingrid Philippens Manuscript
More informationThe levels of mrna expression in the mouse brain were measured at 52 dpi after the brains were divided into five regions: cortex, hippocampus,
Supplemental material Supplemental method RNA extraction, reverse transcription, and real-time PCR The levels of mrna expression in the mouse brain were measured at 52 dpi after the brains were divided
More informationTat ( ) Vol. 47 No : Tat. (Cell penetrating peptide,cpp) ( Protein transduction domain, P TD). 1988
47 2 () Vol. 47 No. 2 2008 3 Journal of Xiamen University (Nat ural Science) Mar. 2008 Tat 1, 1 3, 1, 1, 1,2 3 (1., 361005 ; 2., 300192) : Tat. Tat. FITC Tat Alexa Fluor g 5462 () Alexa Fluor g 5942B (
More information, 25Pa. 75Pa N1 P1 ,,N1 P1 N2. ;oddball
294 3 ( 100083) : : (oddball) 14 ( ) (25Pa) (75Pa) : 11 Cz 25Pa 75Pa N1 P1 N2 25Pa N1 P1 75Pa N2 N1 P1 N2 : (75Pa) ;oddball PAIN2EVO KED POTENTIALS IN AN ODDBALL D ESIGN TAO Chun2Li HAN Ji2Sheng L UO Fei
More informationPgc-1a Overexpression Downregulates Pitx3 and Increases Susceptibility to MPTP Toxicity Associated with Decreased Bdnf
Pgc-1a Overexpression Downregulates Pitx3 and Increases Susceptibility to MPTP Toxicity Associated with Decreased Bdnf Joanne Clark 1 *, Jessica M. Silvaggi 2, Tomas Kiselak 1, Kangni Zheng 1, Elizabeth
More informationTITLE: Pharmacological and Behavioral Enhancement of Neuroplasticity in the MPTP- Lesioned Mouse and Nonhuman Primate.
AD Award Number: W81XWH-04-1-0444 TITLE: Pharmacological and Behavioral Enhancement of Neuroplasticity in the MPTP- Lesioned Mouse and Nonhuman Primate. PRINCIPAL INVESTIGATOR: Giselle M. Petzinger, M.D.
More informationTenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia
Fan et al. Journal of Neuroinflammation (2017) 14:256 DOI 10.1186/s12974-017-1036-x RESEARCH Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in
More informationVisualization and simulated animations of pathology and symptoms of Parkinson s disease
Visualization and simulated animations of pathology and symptoms of Parkinson s disease Prof. Yifan HAN Email: bctycan@ust.hk 1. Introduction 2. Biochemistry of Parkinson s disease 3. Course Design 4.
More informationMovement Disorders: A Brief Overview
Movement Disorders: A Brief Overview Albert Hung, MD, PhD Massachusetts General Hospital Harvard Medical School August 17, 2006 Cardinal Features of Parkinsonism Tremor Rigidity Bradykinesia Postural imbalance
More information3 O Methyldopa inhibits astrocyte mediated dopaminergic neuroprotective effects of l DOPA
DOI 10.1186/s12868-016-0289-0 BMC Neuroscience RESEARCH ARTICLE Open Access 3 O Methyldopa inhibits astrocyte mediated dopaminergic neuroprotective effects of l DOPA Masato Asanuma 1,2* and Ikuko Miyazaki
More informationInteractions Between MPTP-Induced and Age-Related Neuronal Death in a Murine Model of Parkinson's Disease
THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES Interactions Between MPTP-Induced and Age-Related Neuronal Death in a Murine Model of Parkinson's Disease William G. Tatton, Carol E. Greenwood, Nadine A.
More informationUSING LUHMES CELLS AS A MODEL SYSTEM TO STUDY DOPAMINERGIC NEURON CELL BIOLOGY. Tigwa H. Davis, Ph.D. Senior Scientist October 16, 2014
USING LUHMES CELLS AS A MODEL SYSTEM TO STUDY DOPAMINERGIC NEURON CELL BIOLOGY Tigwa H. Davis, Ph.D. Senior Scientist October 16, 2014 About ATCC Founded in 1925, ATCC is a non-profit organization with
More informationJ. Neurochem. (2012) 123, JOURNAL OF NEUROCHEMISTRY doi: /jnc.12010
JOURNAL OF NEUROCHEMISTRY 2012 123 771 780 doi: 10.1111/jnc.12010 Beijing Institute for Neuroscience, Beijing Center of Neural Regeneration and Repairing, Key Laboratory for Neurodegenerative Diseases
More informationNeuroprotective effects of fingolimod in mouse models of Parkinson s disease
THE JOURNAL RESEARCH www.fasebj.org Neuroprotective effects of fingolimod in mouse models of Parkinson s disease Peng Zhao,* Xiaoxia Yang,* Liu Yang,* Minshu Li,*, Kristofer Wood, Qiang Liu,*,,1 and Xiaodong
More informationwith partial nigrostriatal lesions (dihydroxyphenylacetic acid/homovanillic acid/striatum)
Proc. Nat!. Acad. Sci. USA Vol. 77, No. 7, pp. 4305-4309, July 1980 Medical Sciences Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions (dihydroxyphenylacetic
More informationCRN 24-mo final report
CRN 24-mo final report Gene transfer studies for cystinosis Principal investigator: Vasiliki Kalatzis, Ph.D. Co-investigator: Eric J. Kremer, Ph.D. Affiliation: Institut Génétique Moléculaire de Montpellier
More informationTime course behavioral features are correlated with Parkinson's disease associated pathology in a 6 hydroxydopamine hemiparkinsonian rat model
3356 MOLECULAR MEDICINE REPORTS 17: 3356-3363, 2018 Time course behavioral features are correlated with Parkinson's disease associated pathology in a 6 hydroxydopamine hemiparkinsonian rat model RUI JUN
More informationThe Pitx3-deficient aphakia mouse: a naturally occurring mouse model of dopamine deficiency van den Munckhof, P.
UvA-DARE (Digital Academic Repository) The Pitx3-deficient aphakia mouse: a naturally occurring mouse model of dopamine deficiency van den Munckhof, P. Link to publication Citation for published version
More informationDeranda B. Lester, Ph.D. Curriculum Vitae
Deranda B. Lester, Ph.D. Curriculum Vitae Office Phone: (901) 678-4213 Email: dbrewer@memphis.edu EDUCATION 2011 Ph.D., General Psychology The University of Memphis, Department of Psychology Research Area:
More informationGlial cell line-derived neurotrophic factor promotes proliferation of neuroglioma cells by up-regulation of cyclins PCNA and Ki-67
European Review for Medical and Pharmacological Sciences Glial cell line-derived neurotrophic factor promotes proliferation of neuroglioma cells by up-regulation of cyclins PCNA and Ki-67 D.-W. QU, Y.
More informationUvA-DARE (Digital Academic Repository) Detecting dopamine dysfunction with pharmacological MRI Schrantee, Anouk. Link to publication
UvA-DARE (Digital Academic Repository) Detecting dopamine dysfunction with pharmacological MRI Schrantee, Anouk Link to publication Citation for published version (APA): Schrantee, A. G. M. (2016). Detecting
More information